Clinical Research Unit - Studies

The University of Arizona Arthritis Center (UAAC) is at the forefront of exciting advancements in arthritis and autoimmune diseases. Clinical trials have been conducted at the UAAC for more than 20 years. The Clinical Research Unit (CRU) offers a great opportunity for individuals who wish to participate in clinical research.

The Food and Drug Administration (FDA) requires that several different types of clinical trials be performed on new medications prior to approval. Subjects may benefit from research as well as contribute to the advancement of science.


The Clinical Research Unit at the UAAC is currently recruiting people who have been diagnosed with rheumatoid arthritis, lupus, osteoarthritis or axial spondyloarthritis to participate in clinical research studies. If you are interested in learning more about research studies involving these diseases, please contact the Clinical Research Unit and speak with a study coordinator.

The Clinical Research Center general email address is


A telephone call to a Clinical Research Coordinator can help to determine an individual's initial eligibility. The individual is then invited to the research clinic to learn specifically what the study will entail and what is expected of him or her. A physician explains the study and all questions will be answered prior to the informed consent document being signed. The individual has the option to withdraw their consent at anytime during the study, for any reason without impact on their current medical care.

Each study has different ratios of how many people receive the investigational drug versus a placebo. All subjects participating in a clinical trial will receive close medical monitoring by a rheumatologist. The clinical research subjects are seen at the University of Arizona Clinical and Translational Science Research Center.


Clinical Research Study

If you’re at least 18 years old and have lupus, you may qualify for a local research study of an investigational medication for managing lupus.
Qualified volunteers will receive at no cost:
•  Study medication
•  Study-related care from a local doctor
•  Reimbursement for your time and travel

Health insurance and referrals aren’t required to participate.

To learn more, please call 520-626-2655 or email


You may be able to participate in one of these studies if you:

  • are 18 years of age or older
  • have been diagnosed with rheumatoid arthritis (RA) for at least 6 months
  • are currently taking methotrexate
  • still have RA symptoms despite having taken an RA medication
  • and are willing to comply with a schedule of medical visits and procedures.

If you are interested in more information or to see if you qualify, please call 520-626-2655 or email


You may qualify to participate if you meet the following criteria:

  • Male or female ages 18 years or older
  • Diagnosis of osteoarthritis in the knee or hip
  • Willing to discontinue all pain medications for osteoarthritis, except for acetaminophen and not use prohibited medication throughout the duration of the study.
  • Acetaminophen and NSAID therapy provided insufficient pain relief for OA.

This study will test the safety and effectiveness of the investigational drug on osteoarthritis pain. The study treatment period will last 4 months, with a 6 month follow-up period. Study related medical care and procedures are provided at no cost to the study participants.

If you are interested in more information or to see if you qualify, please contact clinical research unit at 626-2655 or

For information on clinical trials visit